You May Now Give Yourself A Flu Vaccine At Home With FluMist Home

In today’s world, there are numerous tasks that can now be done at home that were previously only possible in a professional setting. From attending virtual meetings in pajamas to now vaccinating oneself against the flu, the landscape of home-based activities continues to expand. AstraZeneca’s FluMist Home vaccine is the latest addition to this list, offering individuals in 34 eligible states the opportunity to receive the nasal spray vaccine directly at their doorstep.

The FluMist nasal spray vaccine, approved by the FDA in 2003 for individuals aged five to 49, received a significant update in September 2024. This approval marked FluMist as the first self-administered flu vaccine available on the market. Utilizing live but weakened versions of the flu virus, FluMist offers a unique alternative to traditional flu vaccines, which typically use dead or inactivated virus components. The nasal spray delivery method is particularly appealing to those averse to needles, making the vaccination process simpler and more accessible.

While the approval of FluMist Home came too late for the previous flu season, preparations are now underway for the upcoming season. Adults under 50 and parents of children over two can order the vaccine online, complete a medical screening questionnaire, and have the vaccine prescribed by a licensed healthcare professional. Most commercial insurance plans cover the cost of the vaccine, with a nominal fee for shipping and handling.

It’s important to note that individuals over 50 and children under two are not eligible for FluMist Home due to the live virus components. The vaccine’s delivery eligibility varies by state, with 34 states currently permitting home delivery and self-administration. States such as Alaska, Arkansas, and Hawaii do not currently allow for home delivery of the vaccine.

The introduction of FluMist Home has the potential to increase flu vaccination rates, which have hovered around 50% for adults and children in recent years. Achieving herd immunity against the flu relies on a significant portion of the population being vaccinated. The convenience of at-home vaccination may help overcome barriers to getting vaccinated, ultimately benefiting both individuals and the community at large.

As we look ahead to the upcoming flu season, the availability of FluMist Home presents a new opportunity for individuals to protect themselves and others against the flu. By simplifying the vaccination process and offering a convenient at-home option, FluMist Home may play a key role in improving flu vaccination rates and promoting public health.